Affinity Investment Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-50,733
| Closed | -$489K | – | 191 |
|
2023
Q3 | $489K | Hold |
50,733
| – | – | 0.32% | 122 |
|
2023
Q2 | $540K | Sell |
50,733
-11,161
| -18% | -$119K | 0.31% | 125 |
|
2023
Q1 | $651K | Hold |
61,894
| – | – | 0.35% | 115 |
|
2022
Q4 | $767K | Buy |
61,894
+478
| +0.8% | +$5.92K | 0.35% | 105 |
|
2022
Q3 | $636K | Hold |
61,416
| – | – | 0.33% | 110 |
|
2022
Q2 | $708K | Sell |
61,416
-2,490
| -4% | -$28.7K | 0.35% | 100 |
|
2022
Q1 | $804K | Sell |
63,906
-2,460
| -4% | -$30.9K | 0.33% | 110 |
|
2021
Q4 | $774K | Buy |
66,366
+358
| +0.5% | +$4.18K | 0.31% | 120 |
|
2021
Q3 | $862K | Buy |
66,008
+31
| +0% | +$405 | 0.39% | 94 |
|
2021
Q2 | $849K | Hold |
65,977
| – | – | 0.38% | 94 |
|
2021
Q1 | $738K | Hold |
65,977
| – | – | 0.27% | 110 |
|
2020
Q4 | $751K | Buy |
+65,977
| New | +$751K | 0.3% | 93 |
|